SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma
Aurobindo Pharma
BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 12, 16:00
659.60
18 (2.81%)
VOLUME 563,204
LIVE
NSE
Feb 12, 15:58
661.95
22.8 (3.57%)
VOLUME 6,840,095
News on Aurobindo Pharma
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Aurobindo Pharma; target of Rs 943: Prabhudas Lilladher

5.17 pm | 12 Feb 2016 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 943 in its research report dated ...

Buy Aurobindo Pharma; target of Rs 849: EIS

5.05 pm | 12 Feb 2016 |  Source: Moneycontrol.com

EIS is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 849 in its research report dated February 11, 201...

Buy Aurobindo Pharma;target of Rs 940: Axis Securities

4.51 pm | 12 Feb 2016 |  Source: Moneycontrol.com

Axis Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 940 in its research report dated Febr...

Buy Aurobindo Pharma; target of Rs 905: Emkay

10.45 am | 12 Feb 2016 |  Source: Moneycontrol.com

Emkay is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 905 in its research report dated February 1...

Aurobindo Pharma gets USFDA nod for Levofloxacin injection

4.40 pm | 11 Feb 2016 |  Source: PTI

The approval is for Levofloxacin in 5 percent Dextrose injection in the strengths of 250 mg/50 ml, 500 mg/100 ml, and 750 mg/150 ml, single use contai...

Aurobindo Pharma receives USFDA approval for Levofloxacin in Dextrose Injection

11.47 am | 11 Feb 2016 |  Source: Moneycontrol.com

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levofloxacin in 5% Dextrose Inje...

Top 10 stocks: Cipla, ACC and Ambuja Cements declare Q3 

8.55 am | 11 Feb 2016 |  Source: CNBC-TV18

Stocks likely to be in the focus are: Cipla, ACC, Ambuja Cements, Aurobindo Pharma, Petronet LNG, Tata Global Beverage, Blue Dart Express, Tata Motors...

Stocks in news: SBI, Bharti, ACC, Fin Tech, IVRCL, GSK Pharma

8.13 am | 11 Feb 2016 |  Source: CNBC-TV18

SBI | Tata Motors | HUL | Bharti Airtel | Cipla | ACC | Ambuja Cements | Emami | NHPC | Aurobindo Pharma | Visa Steel | Ruchi Soya | Venus Remedies | ...

Like Aurobindo Pharma, Glenmark Pharma: SP Tulsian 

4.10 pm | 10 Feb 2016 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com likes Aurobindo Pharma and Glenmark Pharma....

Where will funding for recovery come from, asks Ajay Srivastava 

3.35 pm | 10 Feb 2016 |  Source: CNBC-TV18

Ajay Srivastava, CEO of Dimensions Consulting says the PSU bank numbers point to one serious issue — should there even be a recovery, what will be t...

Six in Sixty: Stocks you should keep on your radar 

3.26 pm | 10 Feb 2016 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Punjab National Bank, Hindalco, Cairn, Vedanta, Dr Reddy's, ACC, Ambuja, Cipla, I...

Accumulate Aurobindo Pharma, advises Mayuresh Joshi 

11.25 am | 10 Feb 2016 |  Source: CNBC-TV18

Mayuresh Joshi of Angel Broking is of the view that one can accumulate Aurobindo Pharma....

Sell Tata Steel, Hindalco; Divis Lab may head lower: Sukhani 

10.39 am | 10 Feb 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends selling Tata Steel and Hindalco and feels that Aurobindo Pharma and Divis Lab may head lower....

Stocks in focus are Britannia, Hindalco, Aurobindo Pharma 

10.11 am | 10 Feb 2016 |  Source: CNBC-TV18

Stocks likely to be in focus are: Britannia Industries, Apollo Tyres, Aurobindo Pharma, CESC, Dr Reddys Laboratories, Hindalco Industries, Central Ban...

Positive on Britannia Industries, says SP Tulsian 

9.57 am | 10 Feb 2016 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com has a positive view on Britannia Industries....

Aurobindo Pharma Q3 net profit at Rs 534.95 cr

7.34 pm | 09 Feb 2016 |  Source: PTI

The board of the company has approved third interim dividend of 70 per cent at 70 paisa for every share of face value Re 1 for the year 2015-16...

Aurobindo Q3 profit seen up 38%, US biz may support revenue

10.23 am | 09 Feb 2016 |  Source: CNBC-TV18

Operating profit (earnings before interest, tax, depreciation and amortisation) in Q3 is likely to jump 40 percent to Rs 857 crore and margin may expa...

Bull's Eye: Buy CESC, HDIL, Siemens; sell Arvind, Ajanta Pharma 

8.07 am | 09 Feb 2016 |  Source: CNBC-TV18

Ruchit Jain of Angel Broking advises selling Arvind Future with a target of Rs 274....

Prefer pharma, Alembic Pharma looks interesting: Dipan Mehta 

1.14 pm | 08 Feb 2016 |  Source: CNBC-TV18

Dipan Mehta, Member at BSE & NSE is of the view that there are opportunities in pharma stocks and feels that Alembic Pharma looks interesting....

Stocks in news: Jet, Tata Power, Info Edge, PTC India, Sobha

8.01 am | 08 Feb 2016 |  Source: CNBC-TV18

DLF | Jaiprakash Associates | TVS Tyres | Jet Airways | Tata Power | Indo Count | PC Jeweller | Cummins | KPIT Technologies | Rallis India | Glenmark ...

1 2 3 4 5 6 7 8
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.